Genetic Carrier Testing


Genetic carrier testing includes tests for the heterozygous status of a recessively inherited disorder in individuals who, although apparently healthy themselves, have a high risk of transmitting the genetic disorder to their offspring. Carrier testing will allow couples of childbearing age to make informed reproductive decisions. Genetic carrier tests are used by people who have a family history of an inherited disorder or carriership, reproductive partners of carriers and partners of individuals who have the disorder. A prerequisite for knowledge about a possible risk for relatives and the availability of testing is the dissemination of information in the family. Carrier testing can also be offered as a screening test to persons who do not have an a priori increased risk of being a carrier based on their family history. With new genetic testing technologies, it is possible to screen for a growing number of disorders simultaneously.

Key Concepts

  • Reproductive planning is the most important factor motivating genetic carrier testing.
  • Family disclosure of genetic information is a prerequisite to knowledge about the risk and availability of carrier testing.
  • Because of factors impeding the sharing of information in families and factors interfering with the decision about testing, the uptake for carrier testing in high‐risk families is often lower than expected.
  • To minimize (time) constraints and maximize reproductive options, carrier testing before conception is advocated.
  • Carrier screening is the detection of carrier status in persons who do not have an a priori increased risk of being a carrier based on their or their partners' personal or family history.
  • Rapidly evolving genetic testing technologies facilitate carrier screening for a growing number of diseases simultaneously.

Keywords: carrier status; recessive; genetic testing; carrier testing; carrier screening; genetic risk; family communication; psychological impact


Anido A, Carlson LM, Taft L and Sherman SLJ (2005) Women's attitudes toward testing for fragile X carrier status: a qualitative analysis. Journal of Genetic Counseling 14: 295–306.

Bache I, Brondum‐Nielsen K and Tommerup N (2007) Genetic counselling in adult carriers of a balanced chromosomal rearrangement ascertained in childhood: experiences from a nationwide counselling on of translocation carriers. Genetics in Medicine 9: 185–187.

Borry P, Fryns JP, Schotsmans P and Dierickx K (2006) Carrier testing in minors: a systematic review of guidelines and position papers. European Journal of Human Genetics 14: 133–138.

Clarke A, Richards M, Kerzin‐Storrar L, et al. (2005) Genetic professionals' reports of nondisclosure of genetic risk information within families. European Journal of Human Genetics 13: 556–562.

Denayer L, Welkenhuysen M, Evers‐Kiebooms G, Cassiman JJ and Van den Berghe H (1996) The CF carrier status is not associated with a diminished self concept or increased anxiety: results of psychometric testing after at least one year. Clinical Genetics 49: 232–236.

Edwards JG, Feldman G, Goldberg J, et al. (2015) Expanded carrier screening in reproductive medicine‐points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal‐Fetal Medicine. Obstetrics and Gynecology 125: 653–662.

Fanos JH and Johnson JP (1995) Barriers to carrier testing for adult cystic fibrosis sibs: the importance of not knowing. American Journal of Medical Genetics 59: 85–91.

Featherstone K, Atkinson PA, Bharadwaj A and Clarke AJ (2006) Risky Relations: Family and Kinship in the Era of New Genetics. Oxford: Berg.

Fitzpatrick C and Barry C (1986) Communication within families about Duchenne muscular dystrophy. Developmental Medicine and Child Neurology 28: 596–599.

Forrest L, Delatycki M, Curnow L, Skene L and Aitken M (2012) An audit of clinical service examining the uptake of genetic testing by at‐risk family members. Genetics in Medicine 14: 122–128.

Gaff CL, Clarke AJ, Atkinson P, et al. (2007) Process and outcome in communication of genetic information within families: a systematic review. European Journal of Human Genetics 15: 999–1011.

Gregory M, Boddington P, Dimond R, et al. (2007) Communicating about haemophilia within the family: the importance of context and of experience. Haemophilia 13: 189–198.

Gross SJ, Pletcher BA, Monaghan KG and Professional Practice and Guidelines Committee (2008) Carrier screening in individuals of Ashkenazi Jewish descent. Genetics in Medicine 10: 54–56.

Henneman L, Kooij L, Bouman K and Ten Kate LP (2002) Personal experiences of cystic fibrosis (CF) carrier couples prospectively identified in CF families. American Journal of Medical Genetics 110: 324–331.

Henneman L, Borry P, Chokoshvili D, et al (2016) Responsible implementation of expanded carrier screening. European Journal of Human Genetics 24: e1–e12. DOI: 10.1038/ejhg.2015.271.

James CA, Hadley DW, Holtzman NA and Winkelstein JA (2006) How does the mode of inheritance of a genetic condition influence families? A study of guilt, blame, stigma, and understanding of inheritance and reproductive risks in families with X‐linked and autosomal recessive diseases. Genetics in Medicine 8: 234–242.

Kerzin‐Storrar L, Wright C, Williamson PR, et al. (2002) Comparison of genetic services with and without genetic registers: access and attitudes to genetic counselling services among relatives of genetic clinic patients. Journal of Medical Genetics 39: e85.

Lehmann A, Speight BS and Kerzin‐Storrar L (2011) Extended family impact of genetic testing: the experiences of X‐linked carrier grandmothers. Journal of Genetic Counseling 20: 365–373.

Lewis C, Skirton H and Jones R (2011) Can we make assumptions about the psychosocial impact of living as a carrier, based on studies assessing the effects of carrier testing? Journal of Genetic Counseling 20: 80–97.

McClaren BJ, Metcalfe SA, Aitken M, et al. (2010) Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening. European Journal of Human Genetics 18: 1084–1089.

McClaren BJ, Aitken M, Massie J, et al. (2013) Cascade carrier testing after a child is diagnosed with cystic fibrosis through newborn screening: investigating why most relatives do not have testing. Genetics in Medicine 15: 533–540.

McConkie‐Rosell A, Spiridigliozzi GA, Sullivan JA, Dawson DV and Lachiewicz AM (2000) Carrier testing in fragile X syndrome: effect on self‐concept. American Journal of Medical Genetics 92: 336–345.

Miller FA, Robert JS and Hayeems RZ (2009) Questioning the consensus: managing carrier status results generated by newborn screening. American Journal of Public Health 99: 210–215.

Ormond KE, Mills PL, Lester LA and Ross LF (2003) Effect of family history on disclosure patterns of cystic fibrosis carrier status. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 119C: 70–77.

Raspa M, Edwards A, Wheeler AC, Bishop E and Bailey DB Jr (2016) Family communication and cascade testing for Fragile X syndrome. Journal of Genetic Counseling. DOI: 10.1007/s10897-016-9940-2.

Shaw A and Hurst JA (2008) ‘I don't see any point in telling them’: attitudes to sharing genetic information in the family and carrier testing of relatives among British Pakistani adults referred to a genetics clinic. Ethnicity and Health 3: 1–20.

Sorenson JR, Cheuvront B, DeVellis B, et al. (1997) Acceptance of home and clinic‐based cystic fibrosis carrier education and testing by first, second, and third degree relatives of cystic fibrosis patients. American Journal of Medical Genetics 70: 121–129.

Sorenson JR, Jennings‐Grant T and Newman J (2003) Communication about carrier testing within hemophilia A families. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 119C: 3–10.

Vears DF and Metcalfe SA (2015) Carrier testing in children and adolescents. European Journal of Medical Genetics 58: 659–667.

Further Reading

Denayer L, De Boeck K, Evers‐Kiebooms G and Van den Berghe H (1992) The transfer of information about genetic transmission to brothers and sisters of parents with a CF‐child. Birth Defects Original Article Series 28: 149–158.

Forrest K, Simpson SA, Wilson BJ, et al. (2003) To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clinical Genetics 64: 317–326.

Hayeems RZ, Bytautas JP and Miller FA (2008) A systematic review of the effects of disclosing carrier results generated through newborn screening. Journal of Genetic Counseling 17: 538–549.

Ioannou L, McClaren BJ, Massie J, et al. (2014) Population‐based carrier screening for cystic fibrosis: a systematic review of 23 years of research. Genetics in Medicine 16: 207–216.

Wilson BJ, Forrest K, van Teijlingen ER, et al. (2004) Family communication about genetic risk: the little that is known. Community Genetics 7: 15–24.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Henneman, Lidewij, and Cornel, Martina(Jul 2016) Genetic Carrier Testing. In: eLS. John Wiley & Sons Ltd, Chichester. [doi: 10.1002/9780470015902.a0005627.pub3]